The Lung Cancer Channel on VJOncology is supported by Takeda, Novocure and AstraZeneca. These supporters have no influence over the production of the content.
The management of lung cancer is rapidly changing with an acceleration in new therapies and management strategies. This is largely as a result of an increased understanding of the genetics and underlying biology of the disease and our ability to manipulate the immune response. Keep up to date with the latest trials and opinions on The Lung Cancer Channel.
View overview page
The Lung Cancer Channel on VJOncology is supported by Takeda, Novocure and AstraZeneca.
These supporters have no influence over the production of the content.
If you are interested in becoming a supporter of The Lung Channel, please contact us .
